VFA
AGN

Valeo Financial Advisors’s Allergan plc AGN Stock Holding History

Valeo Financial Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-145
Closed -$28K – 2298
2020
Q2 		$28K Sell
145
-2,835
-95% -$526K ﹤0.01% 946
2020
Q1 		$543K Sell
2,980
-137
-4% -$25.8K 0.06% 166
2019
Q4 		$596K Sell
3,117
-139
-4% -$25.1K 0.06% 170
2019
Q3 		$548K Sell
3,256
-693
-18% -$113K 0.06% 165
2019
Q2 		$659K Sell
3,949
-3,537
-47% -$490K 0.08% 156
2019
Q1 		$1.1M Buy
7,486
+1,355
+22% +$196K 0.13% 116
2018
Q4 		$819K Sell
6,131
-1,417
-19% -$232K 0.11% 130
2018
Q3 		$1.19M Sell
7,548
-288
-4% -$52.9K 0.16% 99
2018
Q2 		$1.44M Sell
7,836
-3,256
-29% -$523K 0.2% 84
2018
Q1 		$1.87M Buy
11,092
+3,939
+55% +$661K 0.3% 64
2017
Q4 		$1.17M Buy
7,153
+1,621
+29% +$291K 0.19% 93
2017
Q3 		$1.13M Buy
+5,532
New +$1.29M 0.26% 80

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return

Valeo Financial Advisors's AGN Position: Q3 2020 in Review

Valeo Financial Advisors sold out of Allergan plc (AGN) in Q3 2020, closing a stake of 145 shares — an estimated $28K sold.

Valeo Financial Advisors first reported a position in AGN in Q3 2017 and held it in 12 quarters. The position peaked at $1.87M in Q1 2018. 3 funds tracked by Wall St. Rank hold AGN as of Q3 2020.

  • Valeo Financial Advisors reported no remaining Allergan plc position as of Q3 2020 after selling out during the quarter.
  • Valeo Financial Advisors sold 145 Allergan plc shares in Q3 2020, an estimated $28K.
  • Valeo Financial Advisors first reported a position in Allergan plc in Q3 2017 and held it in 12 quarters.
  • Valeo Financial Advisors's Allergan plc position peaked at $1.87M in Q1 2018.
  • 3 funds tracked by Wall St. Rank held Allergan plc as of Q3 2020.

Based on Valeo Financial Advisors's 13F filing for Q3 2020, filed 28 Oct 2020.